
Jagadishwar Rao Samala
Examiner (ID: 8163, Phone: (571)272-9927 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1215 |
| Issued Applications | 815 |
| Pending Applications | 79 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4922539
[patent_doc_number] => 20080070855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Treatment with anti-VEGF agents to prevent postoperative inflammation and angiogenesis in normal and diseased eyes'
[patent_app_type] => utility
[patent_app_number] => 11/523563
[patent_app_country] => US
[patent_app_date] => 2006-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4232
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070855.pdf
[firstpage_image] =>[orig_patent_app_number] => 11523563
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/523563 | Treatment with anti-VEGF agents to prevent postoperative inflammation and angiogenesis in normal and diseased eyes | Sep 19, 2006 | Abandoned |
Array
(
[id] => 112913
[patent_doc_number] => 07714024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-11
[patent_title] => 'Compositions and methods for the intraocular transport of therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 11/521872
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10955
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/714/07714024.pdf
[firstpage_image] =>[orig_patent_app_number] => 11521872
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/521872 | Compositions and methods for the intraocular transport of therapeutic agents | Sep 14, 2006 | Issued |
Array
(
[id] => 120845
[patent_doc_number] => 07709024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Sustained-release formulation and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/519763
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 13447
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709024.pdf
[firstpage_image] =>[orig_patent_app_number] => 11519763
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/519763 | Sustained-release formulation and uses thereof | Sep 11, 2006 | Issued |
Array
(
[id] => 5246897
[patent_doc_number] => 20070243131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'BIOPOLYMER SYSTEM FOR TISSUE SEALING'
[patent_app_type] => utility
[patent_app_number] => 11/530362
[patent_app_country] => US
[patent_app_date] => 2006-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13400
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243131.pdf
[firstpage_image] =>[orig_patent_app_number] => 11530362
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/530362 | Biopolymer system for tissue sealing | Sep 7, 2006 | Issued |
Array
(
[id] => 4771344
[patent_doc_number] => 20080057002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Non-aqueous compositions containing urea and allantoin and methods for preparing same'
[patent_app_type] => utility
[patent_app_number] => 11/516094
[patent_app_country] => US
[patent_app_date] => 2006-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4426
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057002.pdf
[firstpage_image] =>[orig_patent_app_number] => 11516094
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/516094 | Non-aqueous compositions containing urea and allantoin and methods for preparing same | Sep 5, 2006 | Abandoned |
Array
(
[id] => 8410464
[patent_doc_number] => 08273861
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-25
[patent_title] => 'Method for the use of [11C] carbon monoxide in labeling synthesis of 11C-labelled ketones by photo-induced free radical carbonylation'
[patent_app_type] => utility
[patent_app_number] => 12/065094
[patent_app_country] => US
[patent_app_date] => 2006-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 9447
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12065094
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/065094 | Method for the use of [11C] carbon monoxide in labeling synthesis of 11C-labelled ketones by photo-induced free radical carbonylation | Aug 28, 2006 | Issued |
Array
(
[id] => 5182640
[patent_doc_number] => 20070053986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'System for the liberation of an active principle and its use'
[patent_app_type] => utility
[patent_app_number] => 11/509252
[patent_app_country] => US
[patent_app_date] => 2006-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1397
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053986.pdf
[firstpage_image] =>[orig_patent_app_number] => 11509252
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/509252 | System for the liberation of an active principle and its use | Aug 23, 2006 | Abandoned |
Array
(
[id] => 5148301
[patent_doc_number] => 20070048360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Pharmaceutical compositions with melting point depressant agents and method of making same'
[patent_app_type] => utility
[patent_app_number] => 11/506368
[patent_app_country] => US
[patent_app_date] => 2006-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 23768
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048360.pdf
[firstpage_image] =>[orig_patent_app_number] => 11506368
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/506368 | Pharmaceutical compositions with melting point depressant agents and method of making same | Aug 16, 2006 | Abandoned |
Array
(
[id] => 4687751
[patent_doc_number] => 20080031932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'Transdermal atomoxetine formulations and associated methods'
[patent_app_type] => utility
[patent_app_number] => 11/499912
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8557
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20080031932.pdf
[firstpage_image] =>[orig_patent_app_number] => 11499912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/499912 | Transdermal atomoxetine formulations and associated methods | Aug 3, 2006 | Abandoned |
Array
(
[id] => 5050793
[patent_doc_number] => 20070031338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Embolized cryoablation for treatment of tumors'
[patent_app_type] => utility
[patent_app_number] => 11/496265
[patent_app_country] => US
[patent_app_date] => 2006-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4694
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031338.pdf
[firstpage_image] =>[orig_patent_app_number] => 11496265
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/496265 | Embolized cryoablation for treatment of tumors | Jul 30, 2006 | Abandoned |
Array
(
[id] => 5243010
[patent_doc_number] => 20070021505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Prevention and treatment of ophthalmic complications of diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/486502
[patent_app_country] => US
[patent_app_date] => 2006-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8099
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021505.pdf
[firstpage_image] =>[orig_patent_app_number] => 11486502
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/486502 | Prevention and treatment of ophthalmic complications of diabetes | Jul 13, 2006 | Abandoned |
Array
(
[id] => 5330157
[patent_doc_number] => 20090110634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'RADIOLABELLED NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 11/995693
[patent_app_country] => US
[patent_app_date] => 2006-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8265
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20090110634.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995693
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995693 | RADIOLABELLED NANOPARTICLES | Jul 13, 2006 | Abandoned |
Array
(
[id] => 5428072
[patent_doc_number] => 20090087382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'CONTRAST AGENTS AND METHODS FOR PREPARING CONTRAST AGENTS'
[patent_app_type] => utility
[patent_app_number] => 11/457370
[patent_app_country] => US
[patent_app_date] => 2006-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12650
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20090087382.pdf
[firstpage_image] =>[orig_patent_app_number] => 11457370
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/457370 | Contrast agents and methods for preparing contrast agents | Jul 12, 2006 | Issued |
Array
(
[id] => 5243005
[patent_doc_number] => 20070021500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Methods for neuroprotection'
[patent_app_type] => utility
[patent_app_number] => 11/481601
[patent_app_country] => US
[patent_app_date] => 2006-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19936
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021500.pdf
[firstpage_image] =>[orig_patent_app_number] => 11481601
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/481601 | Methods for neuroprotection | Jul 5, 2006 | Abandoned |
Array
(
[id] => 9401215
[patent_doc_number] => 08691266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-08
[patent_title] => 'Wound dressing material'
[patent_app_type] => utility
[patent_app_number] => 11/427884
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1981
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11427884
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/427884 | Wound dressing material | Jun 29, 2006 | Issued |
Array
(
[id] => 5149499
[patent_doc_number] => 20070049559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of Gelatinase A in ocular cells'
[patent_app_type] => utility
[patent_app_number] => 11/476496
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6120
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20070049559.pdf
[firstpage_image] =>[orig_patent_app_number] => 11476496
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/476496 | Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of Gelatinase A in ocular cells | Jun 27, 2006 | Abandoned |
Array
(
[id] => 5106595
[patent_doc_number] => 20070065472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Benzyl-1,3-thiazolidine-2,4-dione compounds for stimulating or inducing the growth and/or for reducing the loss of keratin fibers'
[patent_app_type] => utility
[patent_app_number] => 11/476053
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10329
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065472.pdf
[firstpage_image] =>[orig_patent_app_number] => 11476053
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/476053 | Benzyl-1,3-thiazolidine-2,4-dione compounds for stimulating or inducing the growth and/or for reducing the loss of keratin fibers | Jun 27, 2006 | Abandoned |
Array
(
[id] => 5056343
[patent_doc_number] => 20070059265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Benzylidene-1,3-thiazolidine-2,4-dione compounds for stimulating or inducing the growth and/or for reducing the loss and/or for increasing the density of keratin fibers'
[patent_app_type] => utility
[patent_app_number] => 11/476123
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8409
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059265.pdf
[firstpage_image] =>[orig_patent_app_number] => 11476123
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/476123 | Benzylidene-1,3-thiazolidine-2,4-dione compounds for stimulating or inducing the growth and/or for reducing the loss and/or for increasing the density of keratin fibers | Jun 27, 2006 | Abandoned |
Array
(
[id] => 5601866
[patent_doc_number] => 20060292211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Ultrasound Enhancement of Drug Release Across Non-Ionic Surfactant Membranes'
[patent_app_type] => utility
[patent_app_number] => 11/427034
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2413
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292211.pdf
[firstpage_image] =>[orig_patent_app_number] => 11427034
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/427034 | Ultrasound enhancement of drug release across non-ionic surfactant membranes | Jun 27, 2006 | Issued |
Array
(
[id] => 5603033
[patent_doc_number] => 20060293378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Method of lowering intraocular pressure'
[patent_app_type] => utility
[patent_app_number] => 11/475587
[patent_app_country] => US
[patent_app_date] => 2006-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4726
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20060293378.pdf
[firstpage_image] =>[orig_patent_app_number] => 11475587
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/475587 | Method of lowering intraocular pressure | Jun 26, 2006 | Abandoned |